/
/
Report issueIn-depth analytics on the fund's activities
Co-Investors
| Name | Tier | Co-investments | Lead Partners | Focus Area | Preferred Stage | Main Funding Countries | Avg. Rounds Raise |
|---|---|---|---|---|---|---|---|
 Goldman Sachs | 2 | 4 | 0 | #Payments+1 | Series B +1 | #United Kingdom + 1 | |
 BNP Paribas | 4 | 3 | 0 | #Payments+1 | Series E +1 | #United States + 1 | |
 J.P. Morgan | 2 | 2 | 0 | #Payments+1 | Series C | #United States | $ 20-50M |
 Accenture | 3 | 2 | 0 | #RWA+1 | Series C | #United States | $ 20-50M |
 Citi Ventures | 4 | 2 | 0 | #Payments+1 | Series C | #United States | $ 20-50M |
 Broadridge | 4 | 2 | 0 | #RWA+1 | Series C | #United States | $ 20-50M |
 Deutsche Borse | 4 | 2 | 0 | #Payments+1 | Series C | #United States | $ 20-50M |
 ASX Limited | 4 | 2 | 0 | #RWA+1 | Series C | #United States | $ 20-50M |
 Nasdaq Ventures | 3 | 1 | 0 | #Payments | Series B | #United Kingdom | |
 DRW Venture Capital | 4 | 1 | 0 | #RWA+1 | Series E | #United States | |
 Citadel Securities | 4 | 1 | 0 | #Payments+1 | Series E | #United States | |
 Virtu Financial | 4 | 1 | 0 | #Payments+1 | Series E | #United States | |
 Mouro Capital | 4 | 1 | 0 | #Payments+1 | #United States | ||
 BNY Mellon | 4 | 1 | 0 | #Payments | Series B | #United Kingdom | |
 Barclays | 4 | 1 | 0 | #Payments | Series B | #United Kingdom | |
 UBS | 4 | 1 | 0 | #Payments | Series B | #United Kingdom | |
 ABN AMRO | 4 | 1 | 0 | #RWA+1 | #United States | ||
 CME Ventures | 4 | 1 | 0 | #Payments+1 | #United States | ||
 PNC | 4 | 1 | 0 | #Payments+1 | #United States | ||
 Euroclear | 5 | 1 | 0 | #Payments | Series B | #United Kingdom |
1 - 20 from 20
Show rows
20